Загрузка...
Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment
Anti-angiogenic and vascular disrupting therapies rely on the dependence of tumors on new blood vessels to sustain tumor growth. We previously reported a potent vascular disrupting agent, a theranostic nanosystem consisting of a tumor vasculature-homing peptide (CGKRK) fused to a pro-apoptotic pepti...
Сохранить в:
| Опубликовано в: : | J Control Release |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5819600/ https://ncbi.nlm.nih.gov/pubmed/29030222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2017.10.006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|